✦ LIBER ✦

Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal–bolus therapy in type 1 and type 2 diabetes

✍ Scribed by Kerlan, Véronique; Gouet, Didier; Marre, Michel; Renard, Éric

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin degludec, an ultra-longacting ba

✍ Simon Heller; John Buse; Miles Fisher; Satish Garg; Michel Marre; Ludwig Merker; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 271 KB

Insulin degludec, an ultra-longacting ba

✍ Alan J Garber; Allen B King; Stefano Del Prato; Seamus Sreenan; Mustafa K Balci; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 284 KB

Insulin degludec – The impact of a new b

✍ Khunti, Kamlesh; Cos, Xavier; Rutten, Guy 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 947 KB

Degludec, a new ultra-long-acting basal

✍ Muñoz Torres, Manuel 📂 Article 📅 2014 🏛 Elsevier ⚖ 499 KB

Comparison of insulin lispro protamine s

✍ A. R. Chacra; M. Kipnes; L. L. Ilag; S. Sarwat; J. Giaconia; J. Chan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

PDB21 COST-EFFECTIVENESS ANALYSIS OF BAS

✍ WJ Valentine; KU Wittrup-Jensen; AJ Palmer; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB